ArticleJournal of general internal medicine2021
Prior Choices of Between-Study Heterogeneity in Contemporary Bayesian Network Meta-analyses: an Empirical Study.
Article in Journal of general internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 6 syntheses or guidelines pooled it, 22 citations in OpenAlex.
- Methodological quality of network meta-analyses of Chinese herbal medicine could be improved: an evidence mapping.Naunyn-Schmiedeberg's archives of pharmacology · 2026Pooled it
- Topical retinoids and risk of major congenital malformations and spontaneous abortion: a systematic review and meta-analysis.Frontiers in drug safety and regulation · 2026Pooled it
- Comparative efficacy and safety of aldosterone synthase inhibitors in hypertension: a Bayesian network meta-analysis of randomised controlled rials.Open heart · 2025Pooled it
- Efficacy of epigenetic agents for older patients with acute myeloid leukemia and myelodysplastic syndrome in randomized controlled trials: a systematic review and network meta-analysis.Clinical and experimental medicine · 2023Pooled it
- Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.BMJ (Clinical research ed.) · 2023Pooled it
- A penalization approach to random-effects meta-analysis.Statistics in medicine · 2022Pooled it
- Methodologies for network meta-analysis of randomised controlled trials in pain, anaesthesia, and perioperative medicine: a narrative review.British journal of anaesthesia · 2025Review
- Tipping point analysis for the between-arm correlation in an arm-based evidence synthesis.BMC medical research methodology · 2024Article
- Predictive P-score for treatment ranking in Bayesian network meta-analysis.BMC medical research methodology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundNetwork meta-analysis (NMA) is a popular tool to compare multiple treatments in medical research. It is frequently implemented via Bayesian methods. The prior choice of between-study heterogeneity is critical in Bayesian NMAs. This study evaluates the impact of different priors for heterogeneity on NMA results.
methodsWe identified all NMAs with binary outcomes published in The BMJ, JAMA, and The Lancet during 2010-2018, and extracted information about their prior choices for heterogeneity. Our primary analyses focused on those with publicly available full data. We re-analyzed the NMAs using 3 commonly-used non-informative priors and empirical informative log-normal priors. We obtained the posterior median odds ratios and 95% credible intervals of all comparisons, assessed the correlation among different priors, and used Bland-Altman plots to evaluate their agreement. The kappa statistic was also used to evaluate the agreement among these priors regarding statistical significance.
resultsAmong the selected Bayesian NMAs, 52.3% did not specify the prior choice for heterogeneity, and 84.1% did not provide rationales. We re-analyzed 19 NMAs with full data available, involving 894 studies, 173 treatments, and 395,429 patients. The correlation among posterior median (log) odds ratios using different priors were generally very strong for NMAs with over 20 studies. The informative priors produced substantially narrower credible intervals than non-informative priors, especially for NMAs with few studies. Bland-Altman plots and kappa statistics indicated strong overall agreement, but this was not always the case for a specific NMA.
conclusionsPriors should be routinely reported in Bayesian NMAs. Sensitivity analyses are recommended to examine the impact of priors, especially for NMAs with relatively small sample sizes. Informative priors may produce substantially narrower credible intervals for such NMAs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.